RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE

      Adult stem cells and tissue engineering strategies for salivary gland regeneration: a review

      한글로보기

      https://www.riss.kr/link?id=A103818394

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Saliva is an important compound produced by the salivary glands and performs numerous functions. Hyposalivation (dry mouth syndrome) is a deleterious condition often resulting from radiotherapy for patients with head and neck cancer, Sjogren’s Syndr...

      Saliva is an important compound produced by the salivary glands and performs numerous functions. Hyposalivation (dry mouth syndrome) is a deleterious condition often resulting from radiotherapy for patients with head and neck cancer, Sjogren’s Syndrome, or as a side effect of certain medications. Hyposalivation negatively affects speaking, mastication, and swallowing in afflicted patients, greatly reducing their quality of life. Current treatments for this pathology include modifying lifestyle, synthetic saliva supplementation, and the utilization of salivary gland stimulants and sialagogues. However, many of these treatments do not address the underlying issues and others are pervaded by numerous side effects. In order to address the shortcomings related to current treatment modalities, many groups have diverted their attention to utilizing tissue engineering and regenerative medicine approaches. Tissue engineering is defined as the application of life sciences and materials engineering toward the development of tissue substitutes that are capable of mimicking the structure and function of their natural analogues within the body. The general underlying strategy behind the development of tissue engineered organ substitutes is the utilization of a combination of cells, biomaterials, and biochemical cues intended to recreate the natural organ environment. The purpose of this review is to highlight current bioengineering approaches for salivary gland tissue engineering and the adult stem cell sources used for this purpose. Additionally, future considerations in regard to salivary gland tissue engineering strategies are discussed.

      더보기

      참고문헌 (Reference)

      1 Levy O, "mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation" 122 : e23-e32, 2013

      2 Fox RI, "Use of muscarinic agonists in the treatment of Sjogren’s syndrome" 101 : 249-263, 2001

      3 Zheng C, "Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland" 12 : 3-10, 2010

      4 Huang GL, "Transdifferentiation of human amniotic epithelial cells into acinar cells using a double-chamber system" 14 : 377-383, 2012

      5 Tabata Y, "Tissue regeneration based on growth factor release" 9 (9): S5-S15, 2003

      6 Langer R, "Tissue engineering" 260 : 920-926, 1993

      7 Thomson WM, "The impact of xerostomia on oral-health-related quality of life among younger adults" 4 : 86-, 2006

      8 Nakao K, "The development of a bioengineered organ germ method" 4 : 227-230, 2007

      9 Caplan AI, "The MSC: an injury drugstore" 9 : 11-15, 2011

      10 Lim JY, "Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage" 8 : e71167-, 2013

      1 Levy O, "mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation" 122 : e23-e32, 2013

      2 Fox RI, "Use of muscarinic agonists in the treatment of Sjogren’s syndrome" 101 : 249-263, 2001

      3 Zheng C, "Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland" 12 : 3-10, 2010

      4 Huang GL, "Transdifferentiation of human amniotic epithelial cells into acinar cells using a double-chamber system" 14 : 377-383, 2012

      5 Tabata Y, "Tissue regeneration based on growth factor release" 9 (9): S5-S15, 2003

      6 Langer R, "Tissue engineering" 260 : 920-926, 1993

      7 Thomson WM, "The impact of xerostomia on oral-health-related quality of life among younger adults" 4 : 86-, 2006

      8 Nakao K, "The development of a bioengineered organ germ method" 4 : 227-230, 2007

      9 Caplan AI, "The MSC: an injury drugstore" 9 : 11-15, 2011

      10 Lim JY, "Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage" 8 : e71167-, 2013

      11 Berk L, "Systemic pilocarpine for treatment of xerostomia" 4 : 1333-1340, 2008

      12 Okano H, "Steps toward safe cell therapy using induced pluripotent stem cells" 112 : 523-533, 2013

      13 Ilancheran S, "Stem cells derived from human fetal membranes display multilineage differentiation potential" 77 : 577-588, 2007

      14 Coppes RP, "Stem cells and the repair of radiation-induced salivary gland damage" 17 : 143-153, 2011

      15 Dawson LJ, "Sjogren’s syndrome-time for a new approach" 39 : 234-237, 2000

      16 Konings AW, "Secondary radiation damage as the main cause for unexpected volume effects:a histopathologic study of the parotid gland" 64 : 98-105, 2006

      17 Romanov YA, "Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord" 21 : 105-110, 2003

      18 Nordgarden H, "Salivary gland function in persons with ectodermal dysplasias" 111 : 371-376, 2003

      19 Edgar W, "Saliva and oral health" British Dental Association 2004

      20 Stephens LC, "Response of parotid gland organ culture to radiation" 120 : 140-153, 1989

      21 Lombaert IM, "Rescue of salivary gland function after stem cell transplantation in irradiated glands" 3 : e2063-, 2008

      22 Kagami H, "Repetitive adenovirus administration to the parotid gland:role of immunological barriers and induction of oral tolerance" 9 : 305-313, 1998

      23 Kojima T, "Regeneration of radiation damaged salivary glands with adipose-derived stromal cells" 121 : 1864-1869, 2011

      24 Zeilstra LJ, "Radiation induced cell loss in rat submandibular gland and its relation to gland function" 76 : 419-429, 2000

      25 Stephens LC, "Radiation apoptosis of serous acinar cells of salivary and lacrimal glands" 67 : 1539-1543, 1991

      26 Jansma J, "Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy" 70 : 2171-2180, 1992

      27 Thomas CE, "Progress and problems with the use of viral vectors for gene therapy" 4 : 346-358, 2003

      28 Cotrim AP, "Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands" 15 : 2101-2106, 2007

      29 Burlage FR, "Parotid and submandibular/sublingual salivary flow during high dose radiotherapy" 61 : 271-274, 2001

      30 Konings AW, "On the mechanism of salivary gland radiosensitivity" 62 : 1187-1194, 2005

      31 Richards Grayson AC, "Multi-pulse drug delivery from a resorbable polymeric microchip device" 2 : 767-772, 2003

      32 Lombaert IM, "Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands" 12 : 1804-1812, 2006

      33 Keating A, "Mesenchymal stromal cells: new directions" 10 : 709-716, 2012

      34 Khalili S, "Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjogren’s-like disease" 7 : e38615-, 2012

      35 Ankrum JA, "Mesenchymal stem cells: immune evasive, not immune privileged" 32 : 252-260, 2014

      36 Phinney DG, "MSCs:science and trials" 19 : 812-, 2013

      37 Kok MR, "Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren’s syndrome" 14 : 1605-1618, 2003

      38 In ’t Anker PS, "Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta" 22 : 1338-1345, 2004

      39 Tsai MS, "Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol" 19 : 1450-1456, 2004

      40 Rotter N, "Isolation and characterization of adult stem cells from human salivary glands" 17 : 509-518, 2008

      41 Epperly MW, "Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL)radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis" 18 : 401-410, 2004

      42 Lim JY, "Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage" 49 : 136-143, 2013

      43 Tanabe K, "Induction of pluripotency by defined factors" 90 : 83-96, 2014

      44 Sershen SR, "Independent Optical Control of Microfluidic Valves Formed from Optomechanically Responsive Nanocomposite Hydrogels" 17 : 1366-1368, 2005

      45 Shan Z, "Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands" 11 : 444-451, 2005

      46 Delporte C, "Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands" 94 : 3268-3273, 1997

      47 Pillemer SR, "Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County" 76 : 593-599, 2001

      48 Cantin M, "In vivo biocompatibility of the PLGA microparticles in parotid gland" 6 : 2412-2418, 2013

      49 Jellema AP, "Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer" 69 : 751-760, 2007

      50 Nafea EH, "Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels" 154 : 110-122, 2011

      51 Schu S, "Immunogenicity of allogeneic mesenchymal stem cells" 16 : 2094-2103, 2012

      52 Nguyen CQ, "IL17: potential therapeutic target in Sjogren’s syndrome using adenovirus-mediated gene transfer" 91 : 54-62, 2011

      53 정재민, "Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands" 생화학분자생물학회 45 : 1-7, 2013

      54 Fukuchi Y, "Human placenta-derived cells have mesenchymal stem/progenitor cell potential" 22 : 649-658, 2004

      55 Woods NB, "Gene therapy:therapeutic gene causing lymphoma" 440 : 1123-, 2006

      56 Somia N, "Gene therapy: trials and tribulations" 1 : 91-99, 2000

      57 Samuni Y, "Gene delivery in salivary glands: from the bench to the clinic" 1812 : 1515-1521, 2011

      58 Kawakami M, "Functional transplantation of salivary gland cells differentiated from mouse early ES cells in vitro" 26 : 80-90, 2013

      59 Ogawa M, "Functional salivary gland regeneration by transplantation of a bioengineered organ germ" 4 : 2498-, 2013

      60 Zhang NN, "Functional regeneration of irradiated salivary glands with human amniotic epithelial cells transplantation" 6 : 2039-2047, 2013

      61 Takahashi K, "Effects of osteogenic induction on mesenchymal cells from fetal and maternal parts of human placenta" 13 : 337-341, 2004

      62 Lodde BM, "Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren’s syndrome" 65 : 195-200, 2006

      63 Pinheiro M, "Ectodermal dysplasias: a clinical classification and a causal review" 53 : 153-162, 1994

      64 Coppes RP, "Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists" 85 : 1055-1063, 2001

      65 Sreebny LM, "Dry mouth, the malevolent symptom: a clinical guide" John Wiley & Sons 2010

      66 West JL, "Drug delivery: pulsed polymers" 2 : 709-710, 2003

      67 Hirsch LR, "Drezek RA, Halas NJ, West JL:Metal nanoshells" 34 : 15-22, 2006

      68 Ship JA, "Diagnosing, managing, and preventing salivary gland disorders" 8 : 77-89, 2002

      69 Baum BJ, "Development of a gene transfer-based treatment for radiation-induced salivary hypofunction" 46 : 4-8, 2010

      70 Hirayama M, "Development and prospects of organ replacement regenerative therapy" 32 (32): S13-S1, 2013

      71 Clauss F, "Dento-craniofacial phenotypes and underlying molecular mechanisms in hypohidrotic ectodermal dysplasia (HED): a review" 87 : 1089-1099, 2008

      72 Lombaert IM, "Cytokine treatment improves parenchymal and vascular damage of salivary glands after irradiation" 14 : 7741-7750, 2008

      73 Nelson J, "Current cell models for bioengineering a salivary gland: a mini-review of emerging technologies" 19 : 236-244, 2013

      74 Pringle S, "Concise review: Adult salivary gland stem cells and a potential therapy for xerostomia" 31 : 613-619, 2013

      75 Braga MA, "Comparison of the effects of pilocarpine and cevimeline on salivary flow" 7 : 126-130, 2009

      76 Vissink A, "Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers" 78 : 983-991, 2010

      77 Silvestre FJ, "Clinical evaluation of a new artificial saliva in spray form for patients with dry mouth" 14 : E8-E11, 2009

      78 Lin CY, "Cell therapy for salivary gland regeneration" 90 : 341-346, 2011

      79 Sumita Y, "Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation" 43 : 80-87, 2011

      80 Calafiore R, "Artificial pancreas to treat type 1 diabetes mellitus" 140 : 197-236, 2007

      81 Griffin MD, "Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?" 91 : 40-51, 2013

      82 Holsinger FC, "Anatomy, function, and evaluation of the salivary glands. In Salivary Gland Disorders" Springer

      83 Janebodin K, "An in vitro culture system for long-term expansion of epithelial and mesenchymal salivary gland cells: role of TGF-beta1 in salivary gland epithelial and mesenchymal differentiation" 2013 : 815-895, 2013

      84 Murphy SV, "Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells" 31 : 62-68, 2013

      85 Murphy S, "Amnion epithelial cell isolation and characterization for clinical use" 2010

      86 Xu J, "Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome" 120 : 3142-3151, 2012

      87 Voutetakis A, "Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates" 18 : 142-150, 2007

      88 Jensen SB, "A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact" 18 : 1061-1079, 2010

      89 Kogler G, "A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential" 200 : 123-135, 2004

      90 Gibson J, "A controlled release pilocarpine buccal insert in the treatment of Sjogren’s syndrome" 202 : E17-, 2007

      91 Zhang X, "A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies" 29 : 4253-4259, 2008

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-03-28 학회명변경 한글명 : 생체재료학회 -> 한국생체재료학회
      영문명 : 미등록 -> The Korean Society For Biomaterials
      KCI등재후보
      2005-03-28 학술지등록 한글명 : 생체재료학회지
      외국어명 : Biomaterials Research
      KCI등재후보
      2004-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.32 0.32 0.3
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.26 0.23 0.511 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼